View in EDS HTML Full Text PDF Full Text

Impact of Splitting or Crushing on the Relative Bioavailability of the Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Single-Tablet Regimen.

Saved in:
Bibliographic Details
Title: Impact of Splitting or Crushing on the Relative Bioavailability of the Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Single-Tablet Regimen.
Authors: Brown K; Janssen Scientific Affairs, LLC, Titusville, NJ, USA., Thomas D; Janssen Research & Development, LLC, Titusville, NJ, USA., McKenney K; Janssen Research & Development, LLC, Titusville, NJ, USA., Reeder M; Janssen Research & Development, LLC, Raritan, NJ, USA., Simonson RB; Janssen Scientific Affairs, LLC, Titusville, NJ, USA., Bicer C; BICER Consulting & Research, Antwerp, Belgium., Nettles RE; Janssen Scientific Affairs, LLC, Titusville, NJ, USA., Crauwels H; Janssen Research & Development, Beerse, Belgium.
Source: Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2019 May; Vol. 8 (4), pp. 541-548. Date of Electronic Publication: 2018 Dec 03.
Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 101572899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2160-7648 (Electronic) Linking ISSN: 2160763X NLM ISO Abbreviation: Clin Pharmacol Drug Dev Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 30508308
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Impact of Splitting or Crushing on the Relative Bioavailability of the Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Single-Tablet Regimen.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Brown+K%22">Brown K</searchLink>; Janssen Scientific Affairs, LLC, Titusville, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Thomas+D%22">Thomas D</searchLink>; Janssen Research & Development, LLC, Titusville, NJ, USA.<br /><searchLink fieldCode="AU" term="%22McKenney+K%22">McKenney K</searchLink>; Janssen Research & Development, LLC, Titusville, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Reeder+M%22">Reeder M</searchLink>; Janssen Research & Development, LLC, Raritan, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Simonson+RB%22">Simonson RB</searchLink>; Janssen Scientific Affairs, LLC, Titusville, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Bicer+C%22">Bicer C</searchLink>; BICER Consulting & Research, Antwerp, Belgium.<br /><searchLink fieldCode="AU" term="%22Nettles+RE%22">Nettles RE</searchLink>; Janssen Scientific Affairs, LLC, Titusville, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Crauwels+H%22">Crauwels H</searchLink>; Janssen Research & Development, Beerse, Belgium.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101572899%22">Clinical pharmacology in drug development</searchLink> [Clin Pharmacol Drug Dev] 2019 May; Vol. 8 (4), pp. 541-548. <i>Date of Electronic Publication: </i>2018 Dec 03.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101572899 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2160-7648 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222160763X%22">2160763X </searchLink><i>NLM ISO Abbreviation: </i>Clin Pharmacol Drug Dev <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=30508308
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/cpdd.632
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 541
    Titles:
      – TitleFull: Impact of Splitting or Crushing on the Relative Bioavailability of the Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Single-Tablet Regimen.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Brown K
      – PersonEntity:
          Name:
            NameFull: Thomas D
      – PersonEntity:
          Name:
            NameFull: McKenney K
      – PersonEntity:
          Name:
            NameFull: Reeder M
      – PersonEntity:
          Name:
            NameFull: Simonson RB
      – PersonEntity:
          Name:
            NameFull: Bicer C
      – PersonEntity:
          Name:
            NameFull: Nettles RE
      – PersonEntity:
          Name:
            NameFull: Crauwels H
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2019 May
              Type: published
              Y: 2019
          Identifiers:
            – Type: issn-electronic
              Value: 2160-7648
          Numbering:
            – Type: volume
              Value: 8
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Clinical pharmacology in drug development
              Type: main
ResultId 1